3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
51
Neoplasm Metastasis
19
Skin Neoplasms
15
Carcinoma, Renal Cell
13
Leukemia, Myeloid, Acute
12
Kidney Neoplasms
11
Leukemia
9
Neoplasms
7
Uterine Cervical Neoplasms
5
Lymphoma
5
Congenital Abnormalities
5
Breast Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neuroblastoma
4
Myelodysplastic Syndromes
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Carcinoma, Non-Small-Cell Lung
4
Vaginal Neoplasms
2
Penile Neoplasms
2
Papillomavirus Infections
2
Oropharyngeal Neoplasms
2
Melanoma, Experimental
2
Lymphoma, Mantle-Cell
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Erythroblastic, Acute
2
Brain Neoplasms
2
Interventions
Rituximab
9
Whole-Body Irradiation
7
Peripheral Blood Stem Cell Transplantation
7
fludarabine phosphate
6
Cyclophosphamide
6
Etoposide
5
Tacrolimus
4
Mycophenolic Acid
4
Cyclosporine
4
Carboplatin
4
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Busulfan
3
Thiotepa
2
Melphalan
2
Lenalidomide
2
Ipilimumab
2
Dexamethasone
2
Calcium Dobesilate
2
CTLA-4 Antigen
2
Bendamustine Hydrochloride
2
Antilymphocyte Serum
2
veliparib
1
sodium thiosulfate
1
pegfilgrastim
1
oblimersen
1
merphos
1
etoposide phosphate
1
Vorinostat
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Intraocular Lymphoma
×
aldesleukin
×
Clear all
No trials found.